Advanced search
Publication Cover
Clinical Epidemiology Volume 2, 2010 - Issue
Submit an article Journal homepage
60
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Clinical, virological and immunological responses in Danish HIV patients receiving raltegravir as part of a salvage regimen

Frederik N Engsig1 Department of Infectious Diseases, Copenhagen University Hospital, Rigshospitalet, DenmarkCorrespondence[email protected]
,
Jan Gerstoft1 Department of Infectious Diseases, Copenhagen University Hospital, Rigshospitalet, Denmark
,
Gitte Kronborg2 Department of Infectious Diseases, Copenhagen University Hospital, Hvidovre, Denmark
,
Carsten S Larsen3 Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark
,
Gitte Pedersen4 Department of Infectious Diseases, Aalborg University Hospital, Aalborg, Denmark
,
Anne M Audelin5 Department of Virology, Statens Serum Institute, Copenhagen, Denmark
,
Louise B Jørgensen5 Department of Virology, Statens Serum Institute, Copenhagen, Denmark
&
Niels Obel1 Department of Infectious Diseases, Copenhagen University Hospital, Rigshospitalet, Denmark
 show all
Pages 145-151 | Published online: 25 May 2010

References

  • LohseNHansenABPedersenGSurvival of persons with and without HIV infection in Denmark, 1995–2005Ann Intern Med20071462879517227932
  • EngsigFNHansenABGerstoftJKronborgGLarsenCSObelNInpatient admissions and outpatient visits in persons with and without HIV infection in Denmark, 1995–2007AIDS201024345746119786845
  • LohseNObelNKronborgGDeclining risk of triple-class antiretroviral drug failure in Danish HIV-infected individualsAIDS200519881582215867496
  • Department of Health and Human ServicesGuidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescent [online] Available from: http://www.aidsinfonihgov/ContentFiles/AdultandAdolescentGLpdf. Accessed 2010 January 1.
  • DeeksSGTreatment of antiretroviral-drug-resistant HIV-1 infectionLancet200336294002002201114683662
  • LedergerberBLundgrenJDWalkerASPredictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classesLancet20043649428516215234856
  • GulickRMHuXJFiscusSARandomized study of saquinavir with ritonavir or nelfinavir together with delavirdine, adefovir, or both in human immunodeficiency virus-infected adults with virologic failure on indinavir: AIDS Clinical Trials Group Study 359J Infect Dis200018251375138411023461
  • HammerSMVaidaFBennettKKDual vs single protease inhibitor therapy following antiretroviral treatment failure: a randomized trialJAMA2002288216918012095381
  • LedermanMMMillerVWellerIDeeksSGA new approach for ‘deep salvage’ trials in advanced HIV infectionAIDS200721121503150617630543
  • HazudaDJFelockPWitmerMInhibitors of strand transfer that prevent integration and inhibit HIV-1 replication in cellsScience2000287545364665010649997
  • SteigbigelRTCooperDAKumarPNRaltegravir with optimized background therapy for resistant HIV-1 infectionN Engl J Med2008359433935418650512
  • YazdanpanahYFagardCDescampsDHigh rate of virologic suppression with raltegravir plus etravirine and darunavir/ritonavir among treatment-experienced patients infected with multidrug-resistant HIV: results of the ANRS 139 TRIO trialClin Infect Dis20094991441144919814627
  • GrantPMPalmerSBendavidESwitch from enfuvirtide to raltegravir in virologically suppressed HIV-1 infected patients: effects on level of residual viremia and quality of lifeJ Clin Virol200946430530819819183
  • ScherrerAUvon WylVFuxCAImplementation of raltegravir in routine clinical practice: selection criteria for choosing this drug, virologic response rates, and characteristics of failuresJ Acquir Immune Defic Syndr201053446447119841590
  • Statistics Denmark [online] Available from: http://www.sdt.dk. Accessed 2010 January 1.
  • LohseNHansenABJensen-FangelSDemographics of HIV-1 infection in Denmark: results from the Danish HIV Cohort StudyScand J Infect Dis200537533834316051569
  • Jensen-FangelSPedersenLPedersenCThe effect of race/ethnicity on the outcome of highly active antiretroviral therapy for human immunodeficiency virus type 1-infected patientsClin Infect Dis200235121541154812471575
  • ObelNEngsigFNRasmussenLDLarsenMVOmlandLHSorensenHTCohort profile: the Danish HIV cohort studyInt J Epidemiol20093851202120618799495
  • AudelinAMLohseNObelNGerstoftJJorgensenLBThe incidence rate of HIV type-1 drug resistance in patients on antiretroviral therapy: a nationwide population-based Danish cohort study 1999–2005Antivir Ther2009147995100019918103
  • LiuTFShaferRWWeb resources for HIV type 1 genotypic-resistance test interpretationClin Infect Dis200642111608161816652319
  • ArribasJRHorbanAGerstoftJThe MONET trial: darunavir/ritonavir with or without nucleoside analogues, for patients with HIV RNA below 50 copies/mlAIDS201024222323020010070
  • CocohobaJThe SWITCHMRK studies: substitution of lopinavir/ritonavir with raltegravir in HIV-positive individualsExpert Rev Anti Infect Ther20097101159116319968507
  • ThuretIChaixMLTamaletCRaltegravir, etravirine and r-darunavir combination in adolescents with multidrug-resistant virusAIDS200923172364236619823069
  • WilligJHAbanINevinCRComparative regimen durability and discontinuation reasons among 3-class experienced patients in a US clinical cohort [poster]EACs20091111–14Cologne, Germany

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.